QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

OTCMKTS:PARNFParnell Pharmaceuticals Stock Price, Forecast & News

$0.15
+0.01 (+7.14 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.15
Now: $0.15
$0.20
50-Day Range
$0.05
MA: $0.14
$0.30
52-Week Range
$0.04
Now: $0.15
$0.36
Volume12,600 shs
Average Volume7,507 shs
Market Capitalization$2.70 million
P/E RatioN/A
Dividend YieldN/A
Beta2.41
Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal — U.S., Production Animal — Rest of World, and Contract Manufacturing. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for breeding programs in dairy and beef cows; and Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product aids in the treatment of OA for dogs, as well as Reviderm, an anti-microbial liquid bandage for use in companion animals. The company is also developing various products, such as PAR121 for bone-related diseases and injuries in dogs, cats, and horses; and PAR122 for atopic dermatitis and other dermatological conditions, as well as PROCEPT, a next generation breeding program. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PARNF
Previous SymbolNASDAQ:PARN
CUSIPN/A
CIKN/A
Phone61-2-9667-4411

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.67 million

Profitability

Miscellaneous

EmployeesN/A
Market Cap$2.70 million
Next Earnings DateN/A
OptionableNot Optionable
$0.15
+0.01 (+7.14 %)
(As of 08/10/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PARNF News and Ratings via Email

Sign-up to receive the latest news and ratings for PARNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Parnell Pharmaceuticals (OTCMKTS:PARNF) Frequently Asked Questions

How has Parnell Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Parnell Pharmaceuticals' stock was trading at $0.1001 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PARNF shares have increased by 49.9% and is now trading at $0.15.
View which stocks have been most impacted by Coronavirus
.

Has Parnell Pharmaceuticals been receiving favorable news coverage?

Headlines about PARNF stock have been trending somewhat negative on Monday, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Parnell Pharmaceuticals earned a daily sentiment score of -1.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days.
View the latest news about Parnell Pharmaceuticals
.

Who are some of Parnell Pharmaceuticals' key competitors?

Who are Parnell Pharmaceuticals' key executives?

Parnell Pharmaceuticals' management team includes the following people:
  • Dr. Alan Richard Bell, Exec. Chairman (Age 63)
  • Mr. Brad R. McCarthy, CEO, CFO, Chief Accounting Officer & Exec. Director (Age 43)

What is Parnell Pharmaceuticals' stock symbol?

Parnell Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PARNF."

How do I buy shares of Parnell Pharmaceuticals?

Shares of PARNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Parnell Pharmaceuticals' stock price today?

One share of PARNF stock can currently be purchased for approximately $0.15.

How big of a company is Parnell Pharmaceuticals?

Parnell Pharmaceuticals has a market capitalization of $2.70 million and generates $14.67 million in revenue each year.

What is Parnell Pharmaceuticals' official website?

The official website for Parnell Pharmaceuticals is www.parnell.com.

How can I contact Parnell Pharmaceuticals?

Parnell Pharmaceuticals' mailing address is UNIT 4 CENTURY ESTATE 476 GARDENERS ROAD, ALEXANDRIA C3, 2015. The company can be reached via phone at 61-2-9667-4411 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.